109 filings
8-K
Arcturus Therapeutics Holdings, Inc.
1 Aug 19
Entry into a Material Definitive Agreement
12:08pm
8-K
Arcturus Therapeutics Holdings, Inc.
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K
Arcturus Therapeutics Holdings, Inc.
20 May 19
Submission of Matters to a Vote of Security Holders
5:13pm
8-K
Arcturus Therapeutics Holdings, Inc.
13 May 19
Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update
5:13pm
8-K
Arcturus Therapeutics Holdings, Inc.
19 Mar 19
Arcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial Results
12:00am
8-K
kmqtovrx
27 Feb 19
Regulation FD Disclosure
8:00am
8-K
hxwdi5y8718
11 Feb 19
Regulation FD Disclosure
12:00am
6-K
kr9hl8y3fmyopd
6 Nov 18
Current report (foreign)
8:20pm
6-K
qlozze6u2fwct
15 Oct 18
Arct 6-K 2018-10-15
4:36pm
6-K
94ixmrwo 16b
1 Oct 18
Arcturus Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am
6-K
2fnnbpv3f42fq94
28 Sep 18
Current report (foreign)
4:07pm
6-K
zfs87g8y
29 Aug 18
Current report (foreign)
12:00am
6-K
5c407z7
27 Jul 18
Notice of Annual and Extraordinary General Meeting of Shareholders
4:15pm
6-K
g77ui6f9urok2rw9bg
20 Jul 18
Current report (foreign)
5:26pm
6-K
dyps74vjce3d3g cqpo
10 Jul 18
Arcturus Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
4:42pm
6-K
8rf9uw d8
15 Jun 18
Extraordinary General Meeting of Shareholders
5:29pm
6-K
vnsgoe2x
1 Jun 18
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
12:00am
6-K
up7ul61chmsxt
29 May 18
Current report (foreign)
5:16pm
6-K
uq3cgligndsdptmy8
24 May 18
Current report (foreign)
4:30pm
6-K
rx86i7alh5nfx4
21 May 18
ARCTURUS THERAPEUTICS Announces EXTRAORDINARY General Meeting of Shareholders
4:59pm